Expression of the translation initiation factors eIF-4E and eIF-2α is frequently increased in neoplastic cells of Hodgkin lymphoma

Human Pathology

Volumn 39, Issue 6, 2008, Pages 910-916

  Rosenwald, Igor B ^a   Koifman, Larisa ^b   Savas, Lou ^b   Chen, Jane Jane ^c   Woda, Bruce A ^b   Kadin, Marshall E ^d  

^a TUFTS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c HARVARD UNIVERSITY   (United States)

^d ROGER WILLIAMS MEDICAL CENTER   (United States)

Author keywords

Cancer; Hodgkin lymphoma; NF B; Protein synthesis; Translation factors

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INITIATION FACTOR 2ALPHA; INITIATION FACTOR 4E;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CONTROLLED STUDY; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; TUMOR CELL; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; EUKARYOTIC INITIATION FACTOR-2; EUKARYOTIC INITIATION FACTOR-4E; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HODGKIN DISEASE; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHOCYTES; MICE; NF-KAPPA B; NIH 3T3 CELLS; TUMOR MARKERS, BIOLOGICAL;

EID: 44649178786     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2007.10.021     Document Type: Article

References (43)

1. Cohen R.B., Boal T.R., and Safer B. Increased eIF-2 expression in mitogen-activated primary T-lymphocytes. EMBO J 9 (1990) 3831-3837
2. Mao X., Green J.M., Safer B., et al. Regulation of translation initiation factor gene expression during human T cell activation. J Biol Chem 267 (1992) 20444-20450
3. Rosenwald I.B., Rhoads D.B., Callanan L., Isselbacher K.J., and Schmidt E.V. Increased expression of eukaryotic translation initiation factors eIF-4E and eIF-2α in response to growth induction by c-myc. Proc Natl Acad Sci U S A 90 (1993) 6175-6178
4. Rosenwald I.B., Lazaris-Karatzas A., Sonenberg N., and Schmidt E.V. Elevated expression of cyclin Dl in response to increases in initiation factor eIF-4E. Mol Cell Biol 13 (1993) 7358-7363
5. Rosenwald I.B., Kaspar R., Rousseau D., et al. Eukaryotic translation initiation factor 4E regulates expression of cyclin Dl at transcriptional and post-transcriptional levels. J Biol Chem 270 (1995) 21176-21180
6. Sonenberg N. mRNA 5′ cap-binding protein eIF4E and control of cell growth. In: Hershey J.W.B., Mathews M.B., and Sonenberg N. (Eds). Translational control (1996), Cold Spring Harbor Laboratory Press, New York 245-269
7. Raught B., Gingras A.-C., and Sonenberg N. Regulation of ribosomal recruitment in eukaryotes. In: Sonenberg N., Hershey J.W.B., and Mathews M.B. (Eds). Translational control of gene expression (2000), Cold Spring Harbor Laboratory Press, New York 245-293
8. Scorsone K.A., Paniers R., Rowland A.G., and Henshaw E.C. Phosphorylation of eukaryotic initiation factor 2 during physiological stresses which affect protein synthesis. J Biol Chem 262 (1987) 14538-14543
9. Rosenwald I.B. Growth factor-independent expression of the gene encoding translation initiation factor 4E in transformed cell lines. Cancer Lett 98 (1995) 77-82
10. Rosenwald I.B. Upregulated expression of the genes encoding translation initiation factors eIF-4E and eIF-2α in transformed cells. Cancer Lett 102 (1996) 113-123
11. Rosenwald I.B. Deregulation of protein synthesis as a mechanism of neoplastic transformation. Bioessays 18 (1996) 243-249
12. Lazaris-Karatzas A., Montine K.S., and Sonenberg N. Malignant transformation by an eukaryotic initiation factor subunit that binds to mRNA 5′ cap. Nature 345 (1990) 544-547
13. De Benedetti A., and Rhoads R.E. Overexpression of eukaryotic protein synthesis initiation factor 4E in HeLa cells results in aberrant growth and morphology. Proc Natl Acad Sci U S A 87 (1990) 8212-8216
14. Donze O., Jagus R., Koromilas A.E., Hershey J.W.B., and Sonenberg N. Abrogation of translation initiation factor eIF-2 phosphorylation causes malignant transformation of NIH 3T3 cells. EMBO J 14 (1995) 3828-3834
15. Stein H. Hodgkin lymphomas: introduction. In: Jaffe E.S., Harris N.L., Stein H., and Vardiman J.W. (Eds). WHO Health Organization Classification of Tumours. Tumours of Hematopoietic and Lymphoid Tissues (2001), IARC Press, Lyon, France 239
16. Kadin M.E. Hodgkin's disease: cell of origin, immunobiology, and pathogenesis. In: Knowles D.M. (Ed). Neoplastic hematopathology (2001), Lippincott Williams & Wilkins, Philadelphia, PA 667-690
17. Stein H., Delsol G., Pileri S., et al. Classical Hodgkin lymphoma. In: Jaffe E.S., Harris N.L., Stein H., and Vardiman J.W. (Eds). WHO Health Organization Classification of Tumours. Tumours of Hematopoietic and Lymphoid Tissues (2001), IARC Press, Lyon, France 244-253
18. Stein H., Delsol G., Pileri S., et al. Nodular lymphocyte predominant Hodgkin lymphoma. In: Jaffe E.S., Harris N.L., Stein H., and Vardiman J.W. (Eds). WHO Health Organization Classification of Tumours. Tumours of Hematopoietic and Lymphoid Tissues (2001), IARC Press 240-243
19. Skinnider B.F., and Mak T.W. The role of cytokines in classical Hodgkin's lymphoma. Blood 99 (2002) 4283-4297
20. Kadin M.E., and Leibowitz D.N. Cytokines and cytokine receptors in Hodgkin's disease. In: Mauch P.M., Armitage J.O., Diehl V., Hoppe R.T., and Weiss L.M. (Eds). Hodgkin's disease (1999), Lippincott Williams and Wilkins, Philadelphia 139-157
21. Bargou R.C., Leng C., Krappmann D., et al. High-level nuclear NF-κB and Oct-2 is a common feature of cultured Hodgkin/Reed-Sternberg cells. Blood 87 (1996) 4340-4347
22. Bargou R.C., Emmerich F., Krappman D., et al. Constitutive nuclear factor-kB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells. J Clin Invest 100 (1997) 2961-2969
23. Wang S., Rosenwald I.B., Hutzler M., et al. Expression of the eukaryotic translation initiation factors 4E and 2α in non-Hodgkin's lymphomas. Am J Pathol 155 (1999) 247-255
24. Pahl H.L. Activators and target genes of Rel/NF-kB transcription factors. Oncogene 18 (1999) 6853-6866
25. Rayet B., and Gelinas C. Aberrant rel/nfkb genes and activity in human cancer. Oncogene 18 (1999) 6938-6947
26. De Benedetti A., Joshi B., Graff J.R., and Zimmer S.G. CHO cells transformed by the initiation factor eIF-4E display increased c-myc expression but require overexpression of Max for tumorigenicity. Mol Cell Differ 2 (1994) 347-371
27. Shantz L.M., Hu R.-H., and Pegg A.E. Regulation of ornithine decarboxylase in a transformed cell line that overexpresses translation initiation factor eIF-4E. Cancer Res 56 (1996) 3265-3269
28. Kevil K., Carter P., Hu B., and De Benedetti A. Translational enhancement of FGF-2 by eIF-4 factors, and alternate utilization of CUG and AUG codons for translation initiation. Oncogene 11 (1995) 2339-2348
29. Kevil C.G., De Benedetti A., Payne D.K., Coe L.L., Laroux F.S., and Alexander J.S. Translational regulation of vascular permiability factor by eukaryotic initiation factor 4E: implications for tumor angiogenesis. Int J Cancer 65 (1996) 785-790
30. Graff J.R., Boghaert E.R., De Benedetti A., et al. Reduction of translation initiation factor 4E decreases the malignancy of ras-transformed cloned rat embryo fibroblasts. Int J Cancer 60 (1995) 255-263
31. Kozak M. An analysis of vertebrate mRNA sequences: intimations of translational control. J Cell Biol 115 (1991) 887-903
32. Brennan P. Signaling events regulating lymphoid growth and survival. Semin Cancer Biol 11 (2001) 415-421
33. Polunovsky V.A., Rosenwald I.B., Thurik A.T., et al. Translational control of programmed cell death: initiation factor 4E blocks apoptosis in growth factor restricted fibroblasts with physiologically expressed or deregulated Myc. Mol Cell Biol 16 (1996) 6573-6581
34. Rosenwald I.B., Hutzler M., Wang S., Chen J.-J., and Fraire A. Expression of translation initiation factors eIF-4E and eIF-2α is frequently increased in bronchioloalveolar but not in squamous carcinomas of the lung. Cancer 92 (2001) 2164-2171
35. Hanash S.M., Beretta L., Bacroft C.L., et al. Mapping of the gene for interferon-inducible dsRNA-dependent protein kinase to chromosome region 2p21-22: a site of rearrangements in myeloproliferative disorders. Genes Chromosomes Cancer 8 (1993) 34-37
36. Beretta L., Gabbay M., Berger R., Hanash S.M., and Sonenberg N. Expression of the protein kinase PKR is modulated by IRF-1 and is reduced in 5q- associated leukemias. Oncogene 12 (1996) 1593-1596
37. Lu D., and Yunis J.J. Cloning, expression and localization of an RNA helicase gene from a human lymphoid cell line with chromosomal breakpoint 11q23.3. Nucl Acid Res 20 (1992) 1967-1972
38. Seto M., Yamamoto K., Takahashi T., and Ueda R. Cloning and expression of a murine cDNA homologous to the human RCK/p54, a lymphoma-linked chromosomal tramslocation junction gene on 11q23. Gene 166 (1995) 293-296
39. Arai Y., Hosoda F., Kobayashi H., et al. The inv(11)(p15q22) chromosome translocation of de novo and therapy-related myeloid malignancies results in fusion of the nucleoporin gene, NUP98, with the putative RNA helicase gene, DDX10. Blood 89 (1997) 3936-3944
40. Nathan C.-A.O., Liu L., Li B.D.L., Abreo F.W., Nandy I., and DeBenedetti A. Detection of the proto-oncogene eIF-4E in surgical margins may predict recurrence in head and neck cancer. Oncogene 15 (1997) 579-584
41. Rosenwald I.B., Chen J.-J., Wang S., Savas L., London I.M., and Pullman J. Upregulation of protein synthesis initiation factor eIF-4E is an early event during colon carcinogenesis. Oncogene 18 (1999) 2507-2517
42. Peponi E., Drakos E., Reyes G., Leventaki V., Rassidakis G.Z., and Medeiros L.J. Activation of mammalian target of rapamycin signaling promotes cell cycle progression and protects from apoptosis in mantle cell lymphoma. Am J Pathol 169 (2006) 2171-2180
43. Rosenwald I.B. The role of translation in neoplastic transformation from a pathologist's point of view. Oncogene 23 (2004) 3230-3247